PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo

Clinical Cancer Research (2013) - Comments
pubmed: 23204129 doi: 10.1158/1078-0432.ccr-12-2799 issn: 1078-0432 issn: 1557-3265

Girija Dasmahapatra, Hiral Patel, Tri Nguyen, Elisa Attkisson, Steven Grant